• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除幽门螺杆菌感染是否有助于使血脂和 CRP 水平恢复正常?

Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?

作者信息

Kanbay Mehmet, Gür Gürden, Yücel Muammer, Yilmaz Ugur, Boyacioğlu Sedat

机构信息

Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Turkey.

出版信息

Dig Dis Sci. 2005 Jul;50(7):1228-31. doi: 10.1007/s10620-005-2764-9.

DOI:10.1007/s10620-005-2764-9
PMID:16047464
Abstract

It is still unclear whether Helicobacter pylori infection is associated with risk factors for coronary artery disease. The aim of this study was to determine whether eradication of H. pylori infection affects serum lipid levels and C-reactive protein (CRP) levels. Seventy-eight patients who had H. pylori antigen positivity in their stools were enrolled. Clarithromycin, 1 g/day, amoxicillin, 2 g/day, and omeprazole, 40 mg/day, were given for 14 days. Serum total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and CRP were measured at baseline and 8 weeks after therapy. According to H. pylori stool antigen study after 8 weeks, individuals in whom H. pylori was eradicated were recruited as group A and those in whom H. pylori was not eradicated formed group B. Group A comprised 57 patients, and group B 21 patients. Patients in group A comprised 32 women and 25 men and their ages ranged from 35 to 59 years. Patients in group B included 13 women and 8 men, aged 32-61 years. No significant difference in LDL, TC, or TG serum levels were found between group A and group B. Although CRP and HDL serum levels were found to be the same before and after treatment in group B, CRP levels were found to decrease and HDL levels to increase significantly in group A (P < 0.05). We conclude that H. pylori infection may affect lipid metabolism in a way that could increase the risk of atherosclerosis. Thus H. pylori infection is an independent risk factor for coronary artery disease.

摘要

幽门螺杆菌感染是否与冠状动脉疾病的危险因素相关仍不清楚。本研究的目的是确定根除幽门螺杆菌感染是否会影响血清脂质水平和C反应蛋白(CRP)水平。纳入了78例粪便幽门螺杆菌抗原呈阳性的患者。给予克拉霉素1g/天、阿莫西林2g/天和奥美拉唑40mg/天,持续14天。在基线和治疗8周后测量血清总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、甘油三酯(TG)和CRP。根据8周后的幽门螺杆菌粪便抗原研究,幽门螺杆菌被根除的个体被招募为A组,未被根除的个体形成B组。A组包括57例患者,B组包括21例患者。A组患者包括32名女性和25名男性,年龄在35至59岁之间。B组患者包括13名女性和8名男性,年龄在32至61岁之间。A组和B组之间的LDL、TC或TG血清水平没有显著差异。虽然B组治疗前后的CRP和HDL血清水平相同,但A组的CRP水平显著降低,HDL水平显著升高(P<0.05)。我们得出结论,幽门螺杆菌感染可能以增加动脉粥样硬化风险的方式影响脂质代谢。因此,幽门螺杆菌感染是冠状动脉疾病的独立危险因素。

相似文献

1
Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?根除幽门螺杆菌感染是否有助于使血脂和 CRP 水平恢复正常?
Dig Dis Sci. 2005 Jul;50(7):1228-31. doi: 10.1007/s10620-005-2764-9.
2
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients.1型糖尿病患者根除幽门螺杆菌感染后脂质和止血模式的改善。
Clin Nutr. 1999 Aug;18(4):227-31. doi: 10.1016/s0261-5614(99)80074-0.
3
Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.幽门螺杆菌根除对胰岛素抵抗、血脂及低度炎症的影响。
South Med J. 2010 Mar;103(3):190-6. doi: 10.1097/SMJ.0b013e3181cf373f.
4
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.幽门螺杆菌(H. pylori)感染与冠状动脉疾病:经皮冠状动脉腔内血管成形术后幽门螺杆菌根除对冠状动脉管腔的影响。人冠状动脉粥样硬化斑块中幽门螺杆菌特异性DNA的检测。
J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.
5
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].[采用甲硝唑的新型一周三联疗法根除幽门螺杆菌:以克拉霉素或阿莫西林作为第二种抗生素]
Med Clin (Barc). 1998 Jan 17;110(1):1-5.
6
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.幽门螺杆菌感染治疗对非溃疡性消化不良患者无效。奥美拉唑联合克拉霉素和阿莫西林治疗一年后效果(OCAY)研究组。
N Engl J Med. 1998 Dec 24;339(26):1875-81. doi: 10.1056/NEJM199812243392602.
7
[Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].[根据剂量和给药方案,采用奥美拉唑、阿莫西林和克拉霉素治疗根除幽门螺杆菌的有效性]
Gastroenterol Hepatol. 1998 Nov;21(9):432-6.
8
Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections?降钙素原和C反应蛋白水平在幽门螺杆菌感染的诊断及随访中有作用吗?
J Med Microbiol. 2004 Jul;53(Pt 7):639-644. doi: 10.1099/jmm.0.05398-0.
9
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.临床实践中,幽门螺杆菌感染的2周三联疗法优于1周疗法:一项大型前瞻性单中心随机研究。
Helicobacter. 2006 Dec;11(6):562-8. doi: 10.1111/j.1523-5378.2006.00459.x.
10
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.连续两种双重疗法(奥美拉唑与阿莫西林或奥美拉唑与克拉霉素)使幽门螺杆菌感染根除率显著提高。一项针对450名西班牙患者的随机研究。
J Gastroenterol. 1996 Nov;31 Suppl 9:48-52.

引用本文的文献

1
Effect of Eradication on Metabolic Parameters and Body Composition including Skeletal Muscle Mass: A Matched Case-Control Study.根除治疗对代谢参数及包括骨骼肌质量在内的身体成分的影响:一项配对病例对照研究。
Gut Liver. 2025 May 15;19(3):346-354. doi: 10.5009/gnl240494. Epub 2025 Apr 25.
2
Helicobacter pylori infection increases the risk of dyslipidemia in Chinese diabetic Population: a retrospective cross-sectional study.幽门螺杆菌感染增加中国糖尿病患者血脂异常的风险:一项回顾性横断面研究。
BMC Infect Dis. 2024 Jul 25;24(1):730. doi: 10.1186/s12879-024-09597-2.
3
The association between Helicobacter pylori infection and the risk for gout in hyperuricemia patients in China - A cross-sectional study.

本文引用的文献

1
Helicobacter pylori infection and respiratory diseases: a review.幽门螺杆菌感染与呼吸道疾病:综述
World J Gastroenterol. 2003 Jan;9(1):5-8. doi: 10.3748/wjg.v9.i1.5.
2
Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction.日本急性心肌梗死患者幽门螺杆菌感染的患病率及其与冠心病危险因素的关联。
Circ J. 2002 Sep;66(9):805-10. doi: 10.1253/circj.66.805.
3
A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men.
中国高尿酸血症患者中幽门螺杆菌感染与痛风风险的关联——一项横断面研究。
Gut Pathog. 2024 Apr 27;16(1):24. doi: 10.1186/s13099-024-00615-x.
4
Traditional and nontraditional lipid parameters in infection.感染中的传统和非传统脂质参数
Biomark Med. 2024;18(7):291-300. doi: 10.2217/bmm-2023-0453. Epub 2024 Jun 12.
5
Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients.幽门螺杆菌感染对非酒精性脂肪性肝病患者糖代谢、脂代谢及炎性细胞因子的影响
J Multidiscip Healthc. 2024 Mar 14;17:1127-1135. doi: 10.2147/JMDH.S453429. eCollection 2024.
6
The Interplay between and Gut Microbiota in Non-Gastrointestinal Disorders: A Special Focus on Atherosclerosis.与肠道微生物群在非胃肠道疾病中的相互作用:特别关注动脉粥样硬化。
Int J Mol Sci. 2023 Dec 15;24(24):17520. doi: 10.3390/ijms242417520.
7
() Infection-Associated Dyslipidemia in the Asir Region of Saudi Arabia.沙特阿拉伯阿西尔地区的感染相关血脂异常。
Life (Basel). 2023 Nov 13;13(11):2206. doi: 10.3390/life13112206.
8
Can neutrophil to lymphocyte ratio be a non-invasive indicator of the presence of duodenal ulcer related in dyspeptic patients?中性粒细胞与淋巴细胞比值能否作为消化不良患者十二指肠溃疡相关性的非侵入性指标?
Pract Lab Med. 2023 Jun 25;36:e00319. doi: 10.1016/j.plabm.2023.e00319. eCollection 2023 Aug.
9
The Effects of Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial.根除治疗对非糖尿病非酒精性脂肪性肝炎患者肝功能和代谢指标的影响:一项为期5年的随机临床试验
Middle East J Dig Dis. 2022 Jan;14(1):85-95. doi: 10.34172/mejdd.2022.260. Epub 2022 Jan 30.
10
A Comprehensive Survey of the Relationship between Infection and Atherosclerosis in the Iranian Population: A Systematic Review and Meta-analysis.伊朗人群中感染与动脉粥样硬化关系的全面调查:系统评价和荟萃分析。
Arch Iran Med. 2022 Apr 1;25(4):257-266. doi: 10.34172/aim.2022.42.
一项针对社会经济背景相似的美国男性幽门螺杆菌血清阳性与未来心肌梗死风险的前瞻性研究。
Ann Intern Med. 2001 Aug 7;135(3):184-8. doi: 10.7326/0003-4819-135-3-200108070-00010.
4
Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors.幽门螺杆菌和肺炎衣原体的联合血清阳性与年龄、肥胖及社会因素相关。
J Cardiovasc Risk. 2000 Jun;7(3):191-5. doi: 10.1177/204748730000700305.
5
Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against.幽门螺杆菌是缺血性心脏病的一个病因:反对观点。
Dig Liver Dis. 2000 Jan-Feb;32(1):65-8. doi: 10.1016/s1590-8658(00)80047-x.
6
Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study.幽门螺杆菌感染与早发性心肌梗死:病例对照研究及同胞配对研究
BMJ. 1999 Oct 30;319(7218):1157-62. doi: 10.1136/bmj.319.7218.1157.
7
Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.幽门螺杆菌感染的消化道外表现:事实与假象
Dig Dis Sci. 1999 Feb;44(2):229-36. doi: 10.1023/a:1026677728175.
8
Association of Helicobacter pylori infection with elevated serum lipids.
Atherosclerosis. 1999 Jan;142(1):207-10. doi: 10.1016/s0021-9150(98)00194-4.
9
Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study.在卡菲利前瞻性心脏病研究中幽门螺杆菌感染与13年死亡率及缺血性心脏病发病的关系
Circulation. 1998 Sep 29;98(13):1286-90. doi: 10.1161/01.cir.98.13.1286.
10
Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators.幽门螺杆菌血清阳性与冠心病发病率。社区动脉粥样硬化风险(ARIC)研究调查人员。
Circulation. 1998 Sep 1;98(9):845-50. doi: 10.1161/01.cir.98.9.845.